Jian Jin

Person

Chapel Hill, NC, US

People

Patents Grantslast 30 patents

Information Patent Grant
WD40 repeat domain protein 5 (WDR5) degradation/disruption compound...
- Patent number 12,110,295
- Issue date Oct 8, 2024
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mitogen-activated protein kinase kinase (MEK) degradation compounds...
- Patent number 12,103,924
- Issue date Oct 1, 2024
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bifunction chemical epigenetic modifiers and methods of use
- Patent number 11,905,537
- Issue date Feb 20, 2024
- The University of North Carolina at Chapel Hill
- Nate Hathaway
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
WD40 repeat domain protein 5 (WDR5) degradation/disruption compound...
- Patent number 11,905,291
- Issue date Feb 20, 2024
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating CDK4/6-mediated cancer
- Patent number 11,541,051
- Issue date Jan 3, 2023
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for treating EZH2-mediated cancer
- Patent number 11,510,920
- Issue date Nov 29, 2022
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serine threonine kinase (AKT) degradation / disruption compounds an...
- Patent number 11,472,799
- Issue date Oct 18, 2022
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of microbial beta-glucuronidase enzymes and uses thereof
- Patent number 11,339,178
- Issue date May 24, 2022
- The University of North Carolina at Chapel Hill
- Matthew R. Redinbo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating CDK4/6-mediated cancer
- Patent number 11,285,150
- Issue date Mar 29, 2022
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for the treatment of Prader-Willi syndrome
- Patent number 11,278,550
- Issue date Mar 22, 2022
- Duke University
- Yong-hui Jiang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterochromatin gene repression inhibitors
- Patent number 11,254,654
- Issue date Feb 22, 2022
- The University of North Carolina at Chapel Hill
- Nate Hathaway
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Functionally selective ligands of dopamine D2 receptors
- Patent number 9,156,822
- Issue date Oct 13, 2015
- The University of North Carolina at Chapel Hill
- Jian Jin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
NEW COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
- Publication number 20240327427
- Publication date Oct 3, 2024
- Icahn School of Medicine at Mount Sinai
- Bin Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL CHEMICAL EPIGENENTIC MODIFIERS AND METHODS OF USE
- Publication number 20240287492
- Publication date Aug 29, 2024
- The University of North Carolina at Chapel Hill
- Nate Hathaway
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTACS WITH TRANSCRIPTION FACTOR TARGETING MOIETIES
- Publication number 20240131173
- Publication date Apr 25, 2024
- Beth Israel Deaconess Medical Center, Inc.
- Wenyi WEI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHENOTHIAZINE COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AN...
- Publication number 20240025868
- Publication date Jan 25, 2024
- Icahn School of Medicine at Mount Sinai
- Charles Mobbs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROBIFUNCTIONAL COMPOUNDS AS DEGRADERS OF ENL
- Publication number 20230391765
- Publication date Dec 7, 2023
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER-SELECTIVE TARGET DEGRADATION BY TARGETING GROUP CAGED PROTACS
- Publication number 20230364243
- Publication date Nov 16, 2023
- Beth Israel Deaconess Medical Center, Inc.
- Wenyi WEI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA
- Publication number 20230242496
- Publication date Aug 3, 2023
- Icahn School of Medicine at Mount Sinai
- Jian JIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SERINE THREONINE KINASE (AKT) DEGRADATION / DISRUPTION COMPOUNDS AN...
- Publication number 20230167106
- Publication date Jun 1, 2023
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- G01 - MEASURING TESTING
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING EZH2-MEDIATED CANCER
- Publication number 20230114294
- Publication date Apr 13, 2023
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEIN TYROSINE KINASE 6 (PTK6) DEGRADATION / DISRUPTION COMPOUNDS...
- Publication number 20230070613
- Publication date Mar 9, 2023
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROBIFUNCTIONAL COMPOUNDS AS DEGRADERS OF HPK1
- Publication number 20230022524
- Publication date Jan 26, 2023
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
WD40 REPEAT DOMAIN PROTEIN 5 (WDR5) DEGRADATION / DISRUPTION COMPOU...
- Publication number 20220348580
- Publication date Nov 3, 2022
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHOTO INDUCED CONTROL OF PROTEIN DESTRUCTION
- Publication number 20220288207
- Publication date Sep 15, 2022
- Beth Israel Deaconess Medical Center, Inc.
- Wenyi WEI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods for the Treatment of Prader-Willi Syndrome
- Publication number 20220117967
- Publication date Apr 21, 2022
- DUKE UNIVERSITY
- Yong-hui Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING CDK4/6-MEDIATED CANCER
- Publication number 20220054488
- Publication date Feb 24, 2022
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MITOGEN-ACTIVATED PROTEIN KINASE KINASE (MEK) DEGRADATION COMPOUNDS...
- Publication number 20210395244
- Publication date Dec 23, 2021
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIFUNCTION CHEMICAL EPIGENENTIC MODIFIERS AND METHODS OF USE
- Publication number 20210355476
- Publication date Nov 18, 2021
- The University of North Carolina at Chapel Hill
- Nate Hathaway
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods for Treating ALK-Mediated Cancer
- Publication number 20210283261
- Publication date Sep 16, 2021
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) DEGRADATION / DISRUPTI...
- Publication number 20210261538
- Publication date Aug 26, 2021
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SERINE THREONINE KINASE (AKT) DEGRADATION / DISRUPTION COMPOUNDS AN...
- Publication number 20200399266
- Publication date Dec 24, 2020
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- G01 - MEASURING TESTING
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING EZH2-MEDIATED CANCER
- Publication number 20200338070
- Publication date Oct 29, 2020
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCHROMATIN GENE REPRESSION INHIBITORS
- Publication number 20200181116
- Publication date Jun 11, 2020
- The University of North Carolina at Chapel Hill
- Nate Hathaway
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING CDK4/6-MEDIATED CANCER
- Publication number 20190336503
- Publication date Nov 7, 2019
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF MICROBIAL BETA-GLUCURONIDASE ENZYMES AND USES THEREOF
- Publication number 20190330237
- Publication date Oct 31, 2019
- The University of North Carolina at Chapel Hill
- Matthew R. Redinbo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING EZH2-MEDIATED CANCER
- Publication number 20190255041
- Publication date Aug 22, 2019
- Icahn School of Medicine at Mount Sinai
- Jian Jin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods for the Treatment of Prader-Willi Syndrome
- Publication number 20190201402
- Publication date Jul 4, 2019
- DUKE UNIVERSITY
- Yong-hui Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIPLEXED KINASE INHIBITOR BEADS AND USES THEREOF
- Publication number 20140243239
- Publication date Aug 28, 2014
- Gary Johnson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Novel Functionally Selective Ligands of Dopamine D2 Receptors
- Publication number 20130137679
- Publication date May 30, 2013
- Jian Jin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

WD40 repeat domain protein 5 (WDR5) degradation/disruption compound...

Mitogen-activated protein kinase kinase (MEK) degradation compounds...

Bifunction chemical epigenetic modifiers and methods of use

WD40 repeat domain protein 5 (WDR5) degradation/disruption compound...

Compositions and methods for treating CDK4/6-mediated cancer

Compositions and methods for treating EZH2-mediated cancer

Serine threonine kinase (AKT) degradation / disruption compounds an...

Inhibitors of microbial beta-glucuronidase enzymes and uses thereof

Compositions and methods for treating CDK4/6-mediated cancer

Compositions and methods for the treatment of Prader-Willi syndrome

Heterochromatin gene repression inhibitors

Functionally selective ligands of dopamine D2 receptors

Patents Applicationslast 30 patents

NEW COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

BIFUNCTIONAL CHEMICAL EPIGENENTIC MODIFIERS AND METHODS OF USE

PROTACS WITH TRANSCRIPTION FACTOR TARGETING MOIETIES

PHENOTHIAZINE COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AN...

HETEROBIFUNCTIONAL COMPOUNDS AS DEGRADERS OF ENL

CANCER-SELECTIVE TARGET DEGRADATION BY TARGETING GROUP CAGED PROTACS

SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA

SERINE THREONINE KINASE (AKT) DEGRADATION / DISRUPTION COMPOUNDS AN...

COMPOSITIONS AND METHODS FOR TREATING EZH2-MEDIATED CANCER

PROTEIN TYROSINE KINASE 6 (PTK6) DEGRADATION / DISRUPTION COMPOUNDS...

HETEROBIFUNCTIONAL COMPOUNDS AS DEGRADERS OF HPK1

WD40 REPEAT DOMAIN PROTEIN 5 (WDR5) DEGRADATION / DISRUPTION COMPOU...

PHOTO INDUCED CONTROL OF PROTEIN DESTRUCTION

Compositions and Methods for the Treatment of Prader-Willi Syndrome

COMPOSITIONS AND METHODS FOR TREATING CDK4/6-MEDIATED CANCER

MITOGEN-ACTIVATED PROTEIN KINASE KINASE (MEK) DEGRADATION COMPOUNDS...

BIFUNCTION CHEMICAL EPIGENENTIC MODIFIERS AND METHODS OF USE

Compositions and Methods for Treating ALK-Mediated Cancer

PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) DEGRADATION / DISRUPTI...

SERINE THREONINE KINASE (AKT) DEGRADATION / DISRUPTION COMPOUNDS AN...

COMPOSITIONS AND METHODS FOR TREATING EZH2-MEDIATED CANCER

HETEROCHROMATIN GENE REPRESSION INHIBITORS

COMPOSITIONS AND METHODS FOR TREATING CDK4/6-MEDIATED CANCER

INHIBITORS OF MICROBIAL BETA-GLUCURONIDASE ENZYMES AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING EZH2-MEDIATED CANCER

Compositions and Methods for the Treatment of Prader-Willi Syndrome

MULTIPLEXED KINASE INHIBITOR BEADS AND USES THEREOF

Novel Functionally Selective Ligands of Dopamine D2 Receptors